-
1.METHOD FOR TREATING ATHEROSCLEROSIS EMPLOYING AN aP2 INHIBITOR AND COMBINATION 审中-公开
Title translation: VERFAHREN ZUR BEHANDLUNG VON ATHEROSCLEROSIS MIT EINEM AP2-HEMMER ODER KOMBINATION公开(公告)号:EP1113801A4
公开(公告)日:2002-10-02
申请号:EP99948210
申请日:1999-09-13
Applicant: SQUIBB BRISTOL MYERS CO
Inventor: ROBL JEFFREY A , PARKER REX A , BILLER SCOTT A , JAMIL HARIS , JACOBSON BRUCE L , KODUKULA KRISHNA
IPC: C07D237/14 , A61K31/00 , A61K31/155 , A61K31/22 , A61K31/351 , A61K31/40 , A61K31/403 , A61K31/4045 , A61K31/421 , A61K31/422 , A61K31/4418 , A61K31/496 , A61K31/50 , A61K31/505 , A61K31/513 , A61K31/64 , A61K38/17 , A61K38/28 , A61K45/00 , A61K45/06 , A61P3/04 , A61P3/06 , A61P3/10 , A61P9/10 , A61P43/00 , C07D239/38 , C07D239/56 , C07D263/32 , C07D263/38 , C07D263/46 , C07D413/04 , C07D413/06 , A61K31/42
CPC classification number: A61K45/06 , A61K31/00 , A61K31/421 , A61K31/422 , A61K31/50 , A61K31/505 , A61K31/513 , A61K38/17 , A61K2300/00
-
2.METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND COMBINATION 无效
Title translation: 糖尿病治疗方法的AP2抑制剂及其使用的组合物公开(公告)号:EP1121129A4
公开(公告)日:2002-10-16
申请号:EP99951438
申请日:1999-09-13
Applicant: SQUIBB BRISTOL MYERS CO
Inventor: ROBL JEFFREY A , PARKER REX A , BILLER SCOTT A , JAMIL HARIS , JACOBSON BRUCE L , KODUKULA KRISHNA
IPC: C07D237/14 , A61K31/00 , A61K31/155 , A61K31/22 , A61K31/351 , A61K31/40 , A61K31/403 , A61K31/4045 , A61K31/421 , A61K31/422 , A61K31/4418 , A61K31/496 , A61K31/50 , A61K31/505 , A61K31/513 , A61K31/64 , A61K38/17 , A61K38/28 , A61K45/00 , A61K45/06 , A61P3/04 , A61P3/06 , A61P3/10 , A61P9/10 , A61P43/00 , C07D239/38 , C07D239/56 , C07D263/32 , C07D263/38 , C07D263/46 , C07D413/04 , C07D413/06 , A61K31/42
CPC classification number: A61K45/06 , A61K31/00 , A61K31/421 , A61K31/422 , A61K31/50 , A61K31/505 , A61K31/513 , A61K38/17 , A61K2300/00
-
3.CONFORMATIONALLY RESTRICTED AROMATIC INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND METHOD 失效
Title translation: KONFORMATIONSEINGESCHRÄNKTEAROMATISCHE INHIBITOREN DES MICROSOMALEN TRIGLYCERIDTRANSFERPROTEINS UND VERFAHREN公开(公告)号:EP0904262A4
公开(公告)日:2000-10-04
申请号:EP97903805
申请日:1997-01-13
Applicant: SQUIBB BRISTOL MYERS CO
Inventor: BILLER SCOTT A , DICKSON JOHN K , LAWRENCE R MICHAEL , MAGNIN DAVID R , POSS MICHAEL A , ROBL JEFFREY A , SLUSARCHYK WILLIAM A , SULSKY RICHARD B , TINO JOSEPH A
IPC: A61K31/00 , A61K31/191 , A61K31/34 , A61K31/341 , A61K31/365 , A61K31/366 , A61K31/38 , A61K31/381 , A61K31/382 , A61K31/39 , A61K31/40 , A61K31/4025 , A61K31/403 , A61K31/4035 , A61K31/404 , A61K31/41 , A61K31/415 , A61K31/4184 , A61K31/42 , A61K31/421 , A61K31/425 , A61K31/426 , A61K31/428 , A61K31/433 , A61K31/435 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/445 , A61K31/4468 , A61K31/505 , A61K31/52 , A61K31/535 , C07C17/093 , C07C33/34 , C07C47/453 , C07C49/225 , C07C49/252 , C07C49/563 , C07C49/567 , C07C49/573 , C07C69/00 , C07C205/11 , C07C205/43 , C07C205/55 , C07C233/57 , C07C233/58 , C07C233/59 , C07C233/60 , C07C233/62 , C07C233/63 , C07C233/78 , C07C235/40 , C07C235/56 , C07C237/22 , C07C237/24 , C07C255/41 , C07C259/08 , C07C271/22 , C07C291/04 , C07C311/19 , C07C311/21 , C07C311/37 , C07C311/42 , C07C311/46 , C07C317/12 , C07C321/22 , C07C323/60 , C07D207/32 , C07D207/335 , C07D207/38 , C07D209/08 , C07D209/16 , C07D209/34 , C07D209/38 , C07D209/46 , C07D209/48 , C07D211/60 , C07D211/62 , C07D213/40 , C07D213/64 , C07D213/74 , C07D213/75 , C07D213/80 , C07D213/89 , C07D221/16 , C07D231/56 , C07D233/24 , C07D233/54 , C07D233/78 , C07D233/84 , C07D233/88 , C07D233/90 , C07D235/06 , C07D235/08 , C07D235/16 , C07D235/24 , C07D235/26 , C07D235/28 , C07D235/30 , C07D239/38 , C07D239/42 , C07D239/46 , C07D249/12 , C07D249/14 , C07D249/18 , C07D253/06 , C07D253/07 , C07D263/38 , C07D263/46 , C07D263/58 , C07D271/06 , C07D271/07 , C07D277/20 , C07D277/36 , C07D277/56 , C07D277/74 , C07D285/08 , C07D285/12 , C07D285/125 , C07D295/108 , C07D295/155 , C07D295/185 , C07D307/14 , C07D307/52 , C07D311/84 , C07D317/30 , C07D317/58 , C07D319/06 , C07D327/06 , C07D333/20 , C07D335/14 , C07D335/20 , C07D401/04 , C07D401/12 , C07D403/04 , C07D405/12 , C07D407/12 , C07D409/12 , C07D417/04 , C07D417/12 , C07D471/04 , C07D473/34 , C07D487/04 , C07F7/18 , C07F9/40 , C07F9/58 , C07F9/59 , C07F9/6506 , C07F9/6533 , C07F9/655 , C07C217/04 , A61K31/24 , A61K31/47 , C07D401/08 , C07D403/08 , C07D471/10
CPC classification number: C07F7/1856 , A61K31/191 , A61K31/366 , A61K31/404 , A61K31/4468 , C07C17/093 , C07C47/453 , C07C49/563 , C07C49/567 , C07C49/573 , C07C69/00 , C07C205/11 , C07C205/43 , C07C205/55 , C07C233/58 , C07C233/59 , C07C233/60 , C07C233/62 , C07C233/63 , C07C233/78 , C07C235/40 , C07C235/56 , C07C237/22 , C07C237/24 , C07C255/41 , C07C259/08 , C07C271/22 , C07C291/04 , C07C311/19 , C07C311/21 , C07C311/37 , C07C311/42 , C07C311/46 , C07C317/12 , C07C321/22 , C07C323/60 , C07C2601/02 , C07C2601/14 , C07C2603/00 , C07C2603/18 , C07C2603/32 , C07C2603/74 , C07D207/335 , C07D207/38 , C07D209/08 , C07D209/16 , C07D209/34 , C07D209/38 , C07D209/46 , C07D209/48 , C07D211/60 , C07D211/62 , C07D213/40 , C07D213/64 , C07D213/74 , C07D213/75 , C07D213/80 , C07D213/89 , C07D221/16 , C07D231/56 , C07D233/24 , C07D233/64 , C07D233/84 , C07D233/88 , C07D233/90 , C07D235/06 , C07D235/08 , C07D235/16 , C07D235/24 , C07D235/26 , C07D235/28 , C07D235/30 , C07D239/38 , C07D239/42 , C07D239/47 , C07D249/12 , C07D249/14 , C07D249/18 , C07D253/07 , C07D263/38 , C07D263/46 , C07D263/58 , C07D271/07 , C07D277/36 , C07D277/56 , C07D277/74 , C07D285/08 , C07D285/125 , C07D295/108 , C07D295/155 , C07D295/185 , C07D307/14 , C07D311/84 , C07D317/30 , C07D317/58 , C07D319/06 , C07D327/06 , C07D333/20 , C07D335/14 , C07D401/12 , C07D403/04 , C07D405/12 , C07D407/12 , C07D409/12 , C07D417/04 , C07D417/12 , C07D471/04 , C07D487/04 , C07C25/22
-
4.INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND METHOD 失效
Title translation: 抑制剂的微粒体甘油三酯转运蛋白和方法公开(公告)号:EP0886637A1
公开(公告)日:1998-12-30
申请号:EP96903604
申请日:1996-02-01
Applicant: SQUIBB BRISTOL MYERS CO
Inventor: WETTERAU JOHN R II , SHARP DARU YOUNG , GREGG RICHARD E , BILLER SCOTT A , DICKSON JOHN A , LAWRENCE R MICHAEL , MAGNIN DAVID R , POSS MICHAEL A , ROBL JEFFREY A , SULSKY RICHARD B , TINO JOSEPH A , LAWSON JOHN E , HOLAVA HENRY M , PARTYKA RICHARD A
IPC: A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/445 , A61K31/4468 , A61K31/47 , A61K31/495 , A61K31/505 , A61K31/52 , A61K31/535 , A61P3/06 , A61P9/10 , A61P43/00 , C07D211/00 , C07D211/56 , C07D211/58 , C07D211/60 , C07D211/94 , C07D211/98 , C07D215/38 , C07D217/00 , C07D217/22 , C07D221/16 , C07D241/04 , C07D401/00 , C07D401/04 , C07D401/12 , C07D401/14 , C07D405/06 , C07D405/12 , C07D409/06 , C07D409/12 , C07D409/14 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D419/12 , C07D401/06 , C07D405/04 , C07D409/04
CPC classification number: C07D401/04 , C07D211/58 , C07D211/60 , C07D211/94 , C07D401/12 , C07D401/14 , C07D405/12 , C07D409/06 , C07D409/12 , C07D409/14 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D419/12 , G01N2800/044
Abstract: Compounds are provided which inhibit microsomal triglyceride transfer protein and thus are useful for lowering serum lipids and treating atherosclerosis and related diseases. The compounds have the structure (a, b, c or d) wherein R1 to R6, Q, and X are as defined herein.
-
公开(公告)号:AT264833T
公开(公告)日:2004-05-15
申请号:AT97903805
申请日:1997-01-13
Applicant: SQUIBB BRISTOL MYERS CO
Inventor: BILLER SCOTT A , DICKSON JOHN K , LAWRENCE R MICHAEL , MAGNIN DAVID R , POSS MICHAEL A , ROBL JEFFREY A , SLUSARCHYK WILLIAM A , SULSKY RICHARD B , TINO JOSEPH A
IPC: A61K31/00 , A61K31/191 , A61K31/34 , A61K31/341 , A61K31/365 , A61K31/366 , A61K31/38 , A61K31/381 , A61K31/382 , A61K31/39 , A61K31/40 , A61K31/4025 , A61K31/403 , A61K31/4035 , A61K31/404 , A61K31/41 , A61K31/415 , A61K31/4184 , A61K31/42 , A61K31/421 , A61K31/425 , A61K31/426 , A61K31/428 , A61K31/433 , A61K31/435 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/445 , A61K31/4468 , A61K31/505 , A61K31/52 , A61K31/535 , C07C17/093 , C07C33/34 , C07C47/453 , C07C49/225 , C07C49/252 , C07C49/563 , C07C49/567 , C07C49/573 , C07C69/00 , C07C205/11 , C07C205/43 , C07C205/55 , C07C233/57 , C07C233/58 , C07C233/59 , C07C233/60 , C07C233/62 , C07C233/63 , C07C233/78 , C07C235/40 , C07C235/56 , C07C237/22 , C07C237/24 , C07C255/41 , C07C259/08 , C07C271/22 , C07C291/04 , C07C311/19 , C07C311/21 , C07C311/37 , C07C311/42 , C07C311/46 , C07C317/12 , C07C321/22 , C07C323/60 , C07D207/32 , C07D207/335 , C07D207/38 , C07D209/08 , C07D209/16 , C07D209/34 , C07D209/38 , C07D209/46 , C07D209/48 , C07D211/60 , C07D211/62 , C07D213/40 , C07D213/64 , C07D213/74 , C07D213/75 , C07D213/80 , C07D213/89 , C07D221/16 , C07D231/56 , C07D233/24 , C07D233/54 , C07D233/78 , C07D233/84 , C07D233/88 , C07D233/90 , C07D235/06 , C07D235/08 , C07D235/16 , C07D235/24 , C07D235/26 , C07D235/28 , C07D235/30 , C07D239/38 , C07D239/42 , C07D239/46 , C07D249/12 , C07D249/14 , C07D249/18 , C07D253/06 , C07D253/07 , C07D263/38 , C07D263/46 , C07D263/58 , C07D271/06 , C07D271/07 , C07D277/20 , C07D277/36 , C07D277/56 , C07D277/74 , C07D285/08 , C07D285/12 , C07D285/125 , C07D295/108 , C07D295/155 , C07D295/185 , C07D307/14 , C07D307/52 , C07D311/84 , C07D317/30 , C07D317/58 , C07D319/06 , C07D327/06 , C07D333/20 , C07D335/14 , C07D335/20 , C07D401/04 , C07D401/12 , C07D403/04 , C07D405/12 , C07D407/12 , C07D409/12 , C07D417/04 , C07D417/12 , C07D471/04 , C07D473/34 , C07D487/04 , C07F7/18 , C07F9/40 , C07F9/58 , C07F9/59 , C07F9/6506 , C07F9/6533 , C07F9/655 , C07C217/04 , A61K31/24 , C07D401/08 , C07D403/08 , C07D471/10
-
公开(公告)号:EE200100155A
公开(公告)日:2002-08-15
申请号:EEP200100155
申请日:1999-09-13
Applicant: SQUIBB BRISTOL MYERS CO
Inventor: ROBL JEFFREY A , BILLER SCOTT A , PARKER REX A , JAMIL HARIS , JACOBSON BRUCE L , KODUKULA KRISHNA
IPC: C07D237/14 , A61K31/00 , A61K31/155 , A61K31/22 , A61K31/351 , A61K31/40 , A61K31/403 , A61K31/4045 , A61K31/421 , A61K31/422 , A61K31/4418 , A61K31/496 , A61K31/50 , A61K31/505 , A61K31/513 , A61K31/64 , A61K38/17 , A61K38/28 , A61K45/00 , A61K45/06 , A61P3/04 , A61P3/06 , A61P3/10 , A61P9/10 , A61P43/00 , C07D239/38 , C07D239/56 , C07D263/32 , C07D263/38 , C07D263/46 , C07D413/04 , C07D413/06 , A61K31/42
Abstract: A method is provided for treating atherosclerosis and related diseases, employing an aP2 inhibitor or a combination of an aP2 inhibitor and another antiatherosclerotic agent, for example, an HMG CoA reductase inhibitor such as pravastatin.
-
公开(公告)号:HU0104240A2
公开(公告)日:2002-03-28
申请号:HU0104240
申请日:1999-09-13
Applicant: SQUIBB BRISTOL MYERS CO
Inventor: BILLER SCOTT A , JACOBSON BRUCE L , JAMIL HARIS , KODUKULA KRISHNA , PARKER REX A , ROBL JEFFREY A
IPC: C07D237/14 , A61K31/00 , A61K31/155 , A61K31/22 , A61K31/351 , A61K31/40 , A61K31/403 , A61K31/4045 , A61K31/421 , A61K31/422 , A61K31/4418 , A61K31/496 , A61K31/50 , A61K31/505 , A61K31/513 , A61K31/64 , A61K38/17 , A61K38/28 , A61K45/00 , A61K45/06 , A61P3/04 , A61P3/06 , A61P3/10 , A61P9/10 , A61P43/00 , C07D239/38 , C07D239/56 , C07D263/32 , C07D263/38 , C07D263/46 , C07D413/04 , C07D413/06
Abstract: A method is provided for treating atherosclerosis and related diseases, employing an aP2 inhibitor or a combination of an aP2 inhibitor and another antiatherosclerotic agent, for example, an HMG CoA reductase inhibitor such as pravastatin.
-
公开(公告)号:TR200100773T2
公开(公告)日:2001-07-23
申请号:TR200100773
申请日:1999-09-13
Applicant: SQUIBB BRISTOL MYERS CO
Inventor: ROBL JEFFREY A , PARKER REX A , BILLER SCOTT A , JAMIL HARIS , JACOBSON BRUCE L , KODUKULA KRISHNA
IPC: C07D237/14 , A61K31/00 , A61K31/155 , A61K31/22 , A61K31/351 , A61K31/40 , A61K31/403 , A61K31/4045 , A61K31/421 , A61K31/422 , A61K31/4418 , A61K31/496 , A61K31/50 , A61K31/505 , A61K31/513 , A61K31/64 , A61K38/17 , A61K38/28 , A61K45/00 , A61K45/06 , A61P3/04 , A61P3/06 , A61P3/10 , A61P9/10 , A61P43/00 , C07D239/38 , C07D239/56 , C07D263/32 , C07D263/38 , C07D263/46 , C07D413/04 , C07D413/06
Abstract: A method is provided for treating atherosclerosis and related diseases, employing an aP2 inhibitor or a combination of an aP2 inhibitor and another antiatherosclerotic agent, for example, an HMG CoA reductase inhibitor such as pravastatin.
-
公开(公告)号:PE20001056A1
公开(公告)日:2000-12-24
申请号:PE00094399
申请日:1999-09-17
Applicant: SQUIBB BRISTOL MYERS CO
Inventor: ROBL JEFFREY A , BILLER SCOTT A , JAMIL HARIS , JACOBSON BRUCE L , KODUKULA KRISHNA , PARKER REX A
IPC: C07D237/14 , A61K31/00 , A61K31/155 , A61K31/22 , A61K31/351 , A61K31/40 , A61K31/403 , A61K31/4045 , A61K31/42 , A61K31/421 , A61K31/422 , A61K31/4418 , A61K31/496 , A61K31/50 , A61K31/505 , A61K31/513 , A61K31/64 , A61K38/17 , A61K38/28 , A61K45/00 , A61K45/06 , A61P3/04 , A61P3/06 , A61P3/10 , A61P9/10 , A61P43/00 , C07D239/38 , C07D239/56 , C07D263/32 , C07D263/38 , C07D263/46 , C07D413/04 , C07D413/06
Abstract: SE REFIERE A UN INHIBIDOR DE aP2 CONTIENE UN H QUE ENLAZA A UN DONANTE O RECEPTOR Y FORMA PUENTES DE H Y UN SUSTITUYENTE ADICIONAL DE NATURALEZA HIDROFOBICA; SE CARACTERIZA POR LA DISTANCIA ENTRE EL GRUPO FORMADOR DE PUENTE DE H Y EL SUSTITUYENTE HIDROFOBICO DE 7 A° A 15 A°; TAL COMO a)BENZOILBENCENO SUSTITUIDO O ACIDO BIFENILALCANOICO DE FORMULA A(CH2)n-O-B; A ES UN GRUPO a, b; X ES N O -CR3-; Z ES -R3C=CR3-, -R3C=N-, NR3, O, S, ENTRE OTROS; R1 ES H, ALQUILO, FENILO; R2 Y R3 SON H, ALQUILO; R1 Y R2 FORMAN JUNTOS UN BENCENO; CUANDO X ES N; Z ES -R3C=CR3-; n ES 1,2; B ES UN GRUPO c, d; Y ES OR5, N(OH)R8; R4 Y R5 SON H, ALQUILO; R6 ES H, HALOGENO, NITRO; R7 ES R4CHCOOR5, R4CHN(OH), ENTRE OTROS; b)DERIVADOS DE OXAZOL DE FORMULA II, DONDE R Y R` SON H, ALQUILO C1-C2; R1 Y R2 SON H, HALOGENO, ALQUILOXILO; n ES 3-6. TAMBIEN SE REFIERE A UNA COMBINACION QUE COMPRENDE ADEMAS CON UN AGENTE ANTIDIABETICO TAL COMO METFORMINA, GLIBURIDA, GLIMEPIRIDA, GLIPIRIDA, GLIPIZIDA, CLORPROPAMIDA, GLICAZIDA, ACARBOSA, MIGLITOL, TROGLITAZONA, INSULINA, REPAGLINIDA, NATAGLINIDA; LA RELACION DE INHIBIDOR Y AGENTE ANTIDIABETICO ES 0.01-100:1. EL INHIBIDOR aP2 INHIBE LA FUNCION DE LA PROTEINA aP2 DE UNIR ACIDOS GRASOS LIBRES POR LO QUE PUEDE SER UTIL PARA EL TRATAMIENTO DE LA DIABETES, RESISTENCIA A LA INSULINA, OBESIDAD, HIPERGLICEMIA, HIPERINSULINEMIA
-
公开(公告)号:PE20001047A1
公开(公告)日:2000-12-24
申请号:PE00094499
申请日:1999-09-17
Applicant: SQUIBB BRISTOL MYERS CO
Inventor: ROBL JEFFREY A , PARKER REX A , BILLER SCOTT A , JAMIL HARIS , JACOBSON BRUCE L , KODUKULA KRISHNA
IPC: C07D237/14 , A61K31/00 , A61K31/155 , A61K31/22 , A61K31/351 , A61K31/40 , A61K31/403 , A61K31/4045 , A61K31/42 , A61K31/421 , A61K31/422 , A61K31/4418 , A61K31/496 , A61K31/50 , A61K31/505 , A61K31/513 , A61K31/64 , A61K38/17 , A61K38/28 , A61K45/00 , A61K45/06 , A61P3/04 , A61P3/06 , A61P3/10 , A61P9/10 , A61P43/00 , C07D239/38 , C07D239/56 , C07D263/32 , C07D263/38 , C07D263/46 , C07D413/04 , C07D413/06
Abstract: SE REFIERE A UN INHIBIDOR DE aP2 QUE CONTIENE UN HIDROGENO QUE ENLAZA UN GRUPO DONANTE O RECEPTOR FORMADOR DE PUENTES DE HIDROGENO DE NATURALEZA ACIDA Y UN SUSTITUYENTE DE NATURALEZA HIDROFOBICA SE CARACTERIZA PORQUE LA DISTANCIA ENTRE AMBOS ES DE 7 A° A 15 A°; TAL COMO a)UN BENZOILBENCENO O DERIVADO DEL ACIDO BIFENILALCANOICO DE FORMULA A(CH2)nO-B; A ES UN GRUPO a, b; X ES N, CR3; Z ES -R3C=CR3-, -R3C=N-, ENTRE OTROS; R1 ES H, ALQUILO, FENILO; R2 Y R3 SON H, ALQUILO; R1 Y R2 FORMAN UN BENCENO; CUANDO X ES N; Z ES -R3C=CR3-; n ES 1-2; B ES UN GRUPO c, d; Y ES OR5, NOHR8; R4 Y R5 SON H, ALQUILO; R6 ES H, HALOGENO, NITRO; R7 ES R4CHCOOR5, R4CHNOHCONH2, R4CHNOHCOR8, ENTRE OTROS; R8 ES ALQUILO; m ES 0-3; b)DERIVADO DE OXAZOL DE FORMULA II, DONDE R Y R` SON H, ALQUILO C1-C2; R1 Y R2 SON H, HALOGENO, ALQUILOXI, n ES 3-6. UN COMPUESTO PREFERIDO DE FORMULA A. TAMBIEN SE REFIERE A UNA COMBINACION QUE COMPRENDE ADEMAS UN AGENTE ANTIATEROESCLEROTICO TAL COMO PRAVASTATIN, LOVASTATIN, SIMVASTATIN, ATORVASTATIN, CERIVASTATIN, FLUVASTATIN. EL INHIBIDOR SE UNE A LA PROTEINA aP2(PROTEINA EN ADIPOSITO UNIDA A ACIDOS GRASOS) E INHIBE LA FUNCION DE UNIR ACIDOS GRASOS LIBRES Y PUEDE SER UTIL PARA TRATAR LA ATEROESCLEROSIS
-
-
-
-
-
-
-
-
-